{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T07:17:30Z","timestamp":1778224650883,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,20]],"date-time":"2014-03-20T00:00:00Z","timestamp":1395273600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s40261-014-0186-1","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T14:23:20Z","timestamp":1395239000000},"page":"361-366","source":"Crossref","is-referenced-by-count":40,"title":["Immediate Neurological Recovery Following Perispinal Etanercept Years After Brain Injury"],"prefix":"10.1007","volume":"34","author":[{"given":"Edward","family":"Tobinick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Rodriguez-Romanacce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey A.","family":"Ignatowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert N.","family":"Spengler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,20]]},"reference":[{"issue":"7","key":"186_CR1","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/WNL.55.7.1052","volume":"55","author":"S Pappata","year":"2000","unstructured":"Pappata S, Levasseur M, Gunn RN, Myers R, Crouzel C, Syrota A, et al. Thalamic microglial activation in ischemic stroke detected in vivo by PET and [11C]PK1195. Neurology. 2000;55(7):1052\u20134.","journal-title":"Neurology"},{"issue":"2\u20133","key":"186_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.forsciint.2004.06.027","volume":"146","author":"SM Gentleman","year":"2004","unstructured":"Gentleman SM, Leclercq PD, Moyes L, Graham DI, Smith C, Griffin WS, et al. Long-term intracerebral inflammatory response after traumatic brain injury. Forensic Sci Int. 2004;146(2\u20133):97\u2013104.","journal-title":"Forensic Sci Int"},{"issue":"2","key":"186_CR3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.neuroimage.2004.09.034","volume":"24","author":"A Gerhard","year":"2005","unstructured":"Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage. 2005;24(2):591\u20135.","journal-title":"Neuroimage"},{"issue":"8","key":"186_CR4","first-page":"1235","volume":"52","author":"H Folkersma","year":"2011","unstructured":"Folkersma H, Boellaard R, Yaqub M, Kloet RW, Windhorst AD, Lammertsma AA, et al. Widespread and prolonged increase in (R)-(11)C-PK11195 binding after traumatic brain injury. J Nucl Med Off Publ Soc Nucl Med. 2011;52(8):1235\u20139.","journal-title":"J Nucl Med Off Publ Soc Nucl Med"},{"issue":"3","key":"186_CR5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/ana.22455","volume":"70","author":"AF Ramlackhansingh","year":"2011","unstructured":"Ramlackhansingh AF, Brooks DJ, Greenwood RJ, Bose SK, Turkheimer FE, Kinnunen KM, et al. Inflammation after trauma: microglial activation and traumatic brain injury. Ann Neurol. 2011;70(3):374\u201383.","journal-title":"Ann Neurol"},{"issue":"Pt 1","key":"186_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/brain\/aws322","volume":"136","author":"VE Johnson","year":"2013","unstructured":"Johnson VE, Stewart JE, Begbie FD, Trojanowski JQ, Smith DH, Stewart W. Inflammation and white matter degeneration persist for years after a single traumatic brain injury. Brain. 2013;136(Pt 1):28\u201342.","journal-title":"Brain"},{"issue":"2","key":"186_CR7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/11588400-000000000-00000","volume":"25","author":"E Tobinick","year":"2011","unstructured":"Tobinick E. Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. CNS Drugs. 2011;25(2):145\u201355.","journal-title":"CNS Drugs"},{"issue":"12","key":"186_CR8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s40263-012-0013-2","volume":"26","author":"E Tobinick","year":"2012","unstructured":"Tobinick E, Kim NM, Reyzin G, Rodriguez-Romanacce H, Depuy V. Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept. CNS Drugs. 2012;26(12):1051\u201370.","journal-title":"CNS Drugs"},{"issue":"2","key":"186_CR9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1529-8027.2001.01010.x","volume":"6","author":"C Sommer","year":"2001","unstructured":"Sommer C, Schafers M, Marziniak M, Toyka KV. Etanercept reduces hyperalgesia in experimental painful neuropathy. J Peripher Nerv Syst. 2001;6(2):67\u201372.","journal-title":"J Peripher Nerv Syst"},{"issue":"4","key":"186_CR10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1471-4159.2010.06969.x","volume":"115","author":"CC Chio","year":"2010","unstructured":"Chio CC, Lin JW, Chang MW, Wang CC, Kuo JR, Yang CZ, et al. Therapeutic evaluation of etanercept in a model of traumatic brain injury. J Neurochem. 2010;115(4):921\u20139.","journal-title":"J Neurochem"},{"issue":"7","key":"186_CR11","doi-asserted-by":"crossref","first-page":"e40065","DOI":"10.1371\/journal.pone.0040065","volume":"7","author":"M Roh","year":"2012","unstructured":"Roh M, Zhang Y, Murakami Y, Thanos A, Lee SC, Vavvas DG, et al. Etanercept, a widely used inhibitor of tumor necrosis factor-alpha (TNF-alpha), prevents retinal ganglion cell loss in a rat model of glaucoma. PLoS One. 2012;7(7):e40065.","journal-title":"PLoS One"},{"key":"186_CR12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/978-0-387-79948-3_886","volume-title":"Encyclopedia of clinical neuropsychology","author":"J Patterson","year":"2011","unstructured":"Patterson J. F-A-S test. In: Kreutzer JS, DeLuca J, Caplan B, editors. Encyclopedia of clinical neuropsychology. New York: Springer Science\u00a0+\u00a0Business Media; 2011. p. 1024."},{"issue":"4","key":"186_CR13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1017\/S031716710000367X","volume":"31","author":"C Gagnon","year":"2004","unstructured":"Gagnon C, Mathieu J, Desrosiers J. Standardized finger-nose test validity for coordination assessment in an ataxic disorder. Can J Neurol Sci Le J Can Sci Neurol. 2004;31(4):484\u20139.","journal-title":"Can J Neurol Sci Le J Can Sci Neurol"},{"issue":"6","key":"186_CR14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/ageing\/afs070","volume":"41","author":"DJ Lanzino","year":"2012","unstructured":"Lanzino DJ, Conner MN, Goodman KA, Kremer KH, Petkus MT, Hollman JH. Values for timed limb coordination tests in a sample of healthy older adults. Age Ageing. 2012;41(6):803\u20137.","journal-title":"Age Ageing"},{"issue":"2","key":"186_CR15","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/BRS.0b013e31821041f8","volume":"37","author":"T Numasawa","year":"2012","unstructured":"Numasawa T, Ono A, Wada K, Yamasaki Y, Yokoyama T, Aburakawa S, et al. Simple foot tapping test as a quantitative objective assessment of cervical myelopathy. Spine. 2012;37(2):108\u201313.","journal-title":"Spine"},{"issue":"4","key":"186_CR16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.acn.2007.01.026","volume":"22","author":"TP Ross","year":"2007","unstructured":"Ross TP, Calhoun E, Cox T, Wenner C, Kono W, Pleasant M. The reliability and validity of qualitative scores for the Controlled Oral Word Association Test. Arch Clin Neuropsychol Off J Natl Acad Neuropsychol. 2007;22(4):475\u201388.","journal-title":"Arch Clin Neuropsychol Off J Natl Acad Neuropsychol"},{"issue":"4","key":"186_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0894-1130(12)80326-7","volume":"6","author":"R Harkonen","year":"1993","unstructured":"Harkonen R, Harju R, Alaranta H. Accuracy of the Jamar dynamometer. J Hand Ther Off J Am Soc Hand Ther. 1993;6(4):259\u201362.","journal-title":"J Hand Ther Off J Am Soc Hand Ther"},{"key":"186_CR18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0005-7894(05)80075-9","volume":"36","author":"T Longwell","year":"2005","unstructured":"Longwell T, Truax P. The differential effects of weekly, monthly, and bimonthly administration of the beck depression inventory-II: psychometric properties and clinical implications. Behav Ther. 2005;36:265\u201375.","journal-title":"Behav Ther"},{"issue":"9","key":"186_CR19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF00868811","volume":"242","author":"NS King","year":"1995","unstructured":"King NS, Crawford S, Wenden FJ, Moss NE, Wade DT. The Rivermead Post Concussion Symptoms Questionnaire: a measure of symptoms commonly experienced after head injury and its reliability. J Neurol. 1995;242(9):587\u201392.","journal-title":"J Neurol"},{"issue":"7","key":"186_CR20","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1046\/j.1460-9568.2000.00140.x","volume":"12","author":"MG Simoni De","year":"2000","unstructured":"De Simoni MG, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, et al. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci. 2000;12(7):2623\u201333.","journal-title":"Eur J Neurosci"},{"issue":"1 Suppl","key":"186_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5698\/1535-7511-14.s2.3","volume":"14","author":"A Vezzani","year":"2014","unstructured":"Vezzani A. Epilepsy and inflammation in the brain: overview and pathophysiology. Epilepsy Currents. 2014;14(1 Suppl):3\u20137.","journal-title":"Epilepsy Currents"},{"issue":"1","key":"186_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","volume":"7","author":"A Vezzani","year":"2011","unstructured":"Vezzani A, French J, Bartfai T, Baram TZ. The role of inflammation in epilepsy. Nat Rev Neurol. 2011;7(1):31\u201340.","journal-title":"Nat Rev Neurol"},{"issue":"2","key":"186_CR23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0301-0082(00)00022-8","volume":"63","author":"JL Jankowsky","year":"2001","unstructured":"Jankowsky JL, Patterson PH. The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol. 2001;63(2):125\u201349.","journal-title":"Prog Neurobiol"},{"issue":"2","key":"186_CR24","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0169-328X(99)00306-X","volume":"75","author":"CR Plata-Salaman","year":"2000","unstructured":"Plata-Salaman CR, Ilyin SE, Turrin NP, Gayle D, Flynn MC, Romanovitch AE, et al. Kindling modulates the IL-1beta system, TNF-alpha, TGF-beta1, and neuropeptide mRNAs in specific brain regions. Brain Res Mol Brain Res. 2000;75(2):248\u201358.","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"186_CR25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.nbd.2004.03.010","volume":"16","author":"NP Turrin","year":"2004","unstructured":"Turrin NP, Rivest S. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol Dis. 2004;16(2):321\u201334.","journal-title":"Neurobiol Dis"},{"issue":"3","key":"186_CR26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.nbd.2005.01.029","volume":"19","author":"S Mraovitch","year":"2005","unstructured":"Mraovitch S, Calando Y, Regnier A, Lamproglou I, Vicaut E. Post-seizures amygdaloallocortical microvascular lesion leading to atrophy and memory impairment. Neurobiol Dis. 2005;19(3):479\u201389.","journal-title":"Neurobiol Dis"},{"key":"186_CR27","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-2094-5-2","volume":"5","author":"EL Tobinick","year":"2008","unstructured":"Tobinick EL, Gross H. Rapid cognitive improvement in Alzheimer\u2019s disease following perispinal etanercept administration. J Neuroinflam. 2008;5:2.","journal-title":"J Neuroinflam"},{"key":"186_CR28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2377-8-27","volume":"8","author":"EL Tobinick","year":"2008","unstructured":"Tobinick EL, Gross H. Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer\u2019s disease. BMC Neurol. 2008;8:27.","journal-title":"BMC Neurol"},{"issue":"3\u20134","key":"186_CR29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.drudis.2008.10.005","volume":"14","author":"E Tobinick","year":"2009","unstructured":"Tobinick E. Perispinal etanercept for neuroinflammatory disorders. Drug Discov Today. 2009;14(3\u20134):168\u201377.","journal-title":"Drug Discov Today"},{"issue":"9","key":"186_CR30","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/11310810-000000000-00000","volume":"23","author":"E Tobinick","year":"2009","unstructured":"Tobinick E. Tumour necrosis factor modulation for treatment of Alzheimer\u2019s disease: rationale and current evidence. CNS Drugs. 2009;23(9):713\u201325.","journal-title":"CNS Drugs"},{"issue":"6","key":"186_CR31","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1586\/ern.10.52","volume":"10","author":"E Tobinick","year":"2010","unstructured":"Tobinick E. Perispinal etanercept: a new therapeutic paradigm in neurology. Expert Rev Neurother. 2010;10(6):985\u20131002.","journal-title":"Expert Rev Neurother"},{"issue":"1","key":"186_CR32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/156720512799015073","volume":"9","author":"E Tobinick","year":"2012","unstructured":"Tobinick E. Deciphering the physiology underlying the rapid clinical effects of perispinal etanercept in Alzheimer\u2019s disease. Curr Alzheimer Res. 2012;9(1):99\u2013109.","journal-title":"Curr Alzheimer Res"},{"issue":"1","key":"186_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jgm.812","volume":"8","author":"E Tobinick","year":"2006","unstructured":"Tobinick E. The cerebrospinal venous system: anatomy, physiology, and clinical implications. Med Gen Med. 2006;8(1):53.","journal-title":"Med Gen Med"},{"issue":"5","key":"186_CR34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1227\/NEU.0b013e3182274865","volume":"69","author":"N Nathoo","year":"2011","unstructured":"Nathoo N, Caris EC, Wiener JA, Mendel E. History of the vertebral venous plexus and the significant contributions of Breschet and Batson. Neurosurgery. 2011;69(5):1007\u201314 (discussion 14).","journal-title":"Neurosurgery."},{"issue":"10","key":"186_CR35","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.pmrj.2013.08.601","volume":"5","author":"F Vox","year":"2013","unstructured":"Vox F, Capron AM, Kraus MF, Alexander GC, Kirschner KL. Balancing burdens and benefits: ethical issues of off-label prescription pharmaceutical use. PM R J Inj Funct Rehabil. 2013;5(10):882\u20139.","journal-title":"PM R J Inj Funct Rehabil"},{"issue":"1","key":"186_CR36","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1517\/14740338.2012.633509","volume":"11","author":"TA Kerensky","year":"2012","unstructured":"Kerensky TA, Gottlieb AB, Yaniv S, Au SC. Etanercept: efficacy and safety for approved indications. Expert Opin Drug Saf. 2012;11(1):121\u201339.","journal-title":"Expert Opin Drug Saf"},{"issue":"Suppl 2","key":"186_CR37","doi-asserted-by":"crossref","first-page":"ii35","DOI":"10.1136\/annrheumdis-2013-consensusapp","volume":"72","author":"DE Furst","year":"2013","unstructured":"Furst DE, Fleischman R, Kalden J, Kavanaugh A, Sieper J, Mease P, et al. Documentation of off-label use of biologics in rheumatoid arthritis. Ann Rheum Dis. 2013;72(Suppl 2):ii35\u201351.","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"186_CR38","first-page":"71","volume":"53","author":"JM Beck","year":"1998","unstructured":"Beck JM, Azari ED. FDA, off-label use, and informed consent: debunking myths and misconceptions. Food Drug Law J. 1998;53(1):71\u2013104.","journal-title":"Food Drug Law J"},{"key":"186_CR39","doi-asserted-by":"crossref","unstructured":"Guidance for off-label use of drugs. Lancet Neurol. 2008;7(4):285.","DOI":"10.1016\/S1474-4422(08)70050-4"},{"key":"186_CR40","doi-asserted-by":"crossref","unstructured":"Committee on Drugs. Policy statement: off-label use of drugs in children. Pediatrics. 2014;133:563\u20137.","DOI":"10.1542\/peds.2013-4060"},{"issue":"9320","key":"186_CR41","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(02)08707-X","volume":"359","author":"DF Horrobin","year":"2002","unstructured":"Horrobin DF. Effective clinical innovation: an ethical imperative. Lancet. 2002;359(9320):1857\u20138.","journal-title":"Lancet"},{"issue":"7023","key":"186_CR42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","volume":"312","author":"DL Sackett","year":"1996","unstructured":"Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn\u2019t. BMJ. 1996;312(7023):71\u20132.","journal-title":"BMJ"},{"key":"186_CR43","first-page":"46","volume-title":"The principles of medical ethics with annotations especially applicable to psychiatry","author":"American Psychiatric Association","year":"2001","unstructured":"American Psychiatric Association. The principles of medical ethics with annotations especially applicable to psychiatry. 2001st ed. Washington: American Psychiatric Association; 2001. p. 46.","edition":"2001"},{"key":"186_CR44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1747-5341-2-26","volume":"2","author":"SN Ghaemi","year":"2007","unstructured":"Ghaemi SN, Goodwin FK. The ethics of clinical innovation in psychopharmacology: challenging traditional bioethics. Philos Ethics Humanit Med. 2007;2:26.","journal-title":"Philos Ethics Humanit Med"},{"key":"186_CR45","volume-title":"Anatomy, descriptive and surgical","author":"H Gray","year":"1866","unstructured":"Gray H, Holmes T. Anatomy, descriptive and surgical. 4th ed. London: Longmans, Green, and Co.; 1866.","edition":"4"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-014-0186-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-014-0186-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-014-0186-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T09:17:08Z","timestamp":1689067028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-014-0186-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,20]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1007\/s40261-014-0186-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,20]]}}}